The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Cardiac Marker Testing Market Research Report 2025

Global Cardiac Marker Testing Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1905686

No of Pages : 81

Ask Your Query

Synopsis

The global Cardiac Marker Testing market was valued at US$ 2462.1 million in 2023 and is anticipated to reach US$ 3569.4 million by 2030, witnessing a CAGR of 5.0% during the forecast period 2024-2030.

North American market for Cardiac Marker Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Cardiac Marker Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Cardiac Marker Testing in Pharmaceutical Companies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Cardiac Marker Testing include Roche Diagnostics, Abbott Laboratories, Siemens, Danaher Corporation, Alere Inc, BioMerieux, LSI Medience Corporation, Ortho Clinical Diagnostics and Randox Laboratories Ltd, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Cardiac Marker Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiac Marker Testing.

Report Scope

The Cardiac Marker Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cardiac Marker Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cardiac Marker Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Roche Diagnostics
  • Abbott Laboratories
  • Siemens
  • Danaher Corporation
  • Alere Inc
  • BioMerieux
  • LSI Medience Corporation
  • Ortho Clinical Diagnostics
  • Randox Laboratories Ltd
  • Guangzhou Wondfo Biotech

Segment by Type

  • Chemiluminescence
  • Immunofluorescence
  • ELISA
  • Immunochromatography
  • Others

Segment by Application

  • Pharmaceutical Companies
  • Reagents Manufacturers
  • Imaging Instrument Providers
  • Others

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cardiac Marker Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cardiac Marker Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Chemiluminescence
1.2.3 Immunofluorescence
1.2.4 ELISA
1.2.5 Immunochromatography
1.2.6 Others
1.3 Market by Application
1.3.1 Global Cardiac Marker Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Companies
1.3.3 Reagents Manufacturers
1.3.4 Imaging Instrument Providers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cardiac Marker Testing Market Perspective (2019-2030)
2.2 Cardiac Marker Testing Growth Trends by Region
2.2.1 Global Cardiac Marker Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cardiac Marker Testing Historic Market Size by Region (2019-2024)
2.2.3 Cardiac Marker Testing Forecasted Market Size by Region (2025-2030)
2.3 Cardiac Marker Testing Market Dynamics
2.3.1 Cardiac Marker Testing Industry Trends
2.3.2 Cardiac Marker Testing Market Drivers
2.3.3 Cardiac Marker Testing Market Challenges
2.3.4 Cardiac Marker Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cardiac Marker Testing Players by Revenue
3.1.1 Global Top Cardiac Marker Testing Players by Revenue (2019-2024)
3.1.2 Global Cardiac Marker Testing Revenue Market Share by Players (2019-2024)
3.2 Global Cardiac Marker Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cardiac Marker Testing Revenue
3.4 Global Cardiac Marker Testing Market Concentration Ratio
3.4.1 Global Cardiac Marker Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cardiac Marker Testing Revenue in 2023
3.5 Cardiac Marker Testing Key Players Head office and Area Served
3.6 Key Players Cardiac Marker Testing Product Solution and Service
3.7 Date of Enter into Cardiac Marker Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cardiac Marker Testing Breakdown Data by Type
4.1 Global Cardiac Marker Testing Historic Market Size by Type (2019-2024)
4.2 Global Cardiac Marker Testing Forecasted Market Size by Type (2025-2030)
5 Cardiac Marker Testing Breakdown Data by Application
5.1 Global Cardiac Marker Testing Historic Market Size by Application (2019-2024)
5.2 Global Cardiac Marker Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cardiac Marker Testing Market Size (2019-2030)
6.2 North America Cardiac Marker Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cardiac Marker Testing Market Size by Country (2019-2024)
6.4 North America Cardiac Marker Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cardiac Marker Testing Market Size (2019-2030)
7.2 Europe Cardiac Marker Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cardiac Marker Testing Market Size by Country (2019-2024)
7.4 Europe Cardiac Marker Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cardiac Marker Testing Market Size (2019-2030)
8.2 Asia-Pacific Cardiac Marker Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cardiac Marker Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Cardiac Marker Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cardiac Marker Testing Market Size (2019-2030)
9.2 Latin America Cardiac Marker Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cardiac Marker Testing Market Size by Country (2019-2024)
9.4 Latin America Cardiac Marker Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cardiac Marker Testing Market Size (2019-2030)
10.2 Middle East & Africa Cardiac Marker Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cardiac Marker Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Cardiac Marker Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche Diagnostics
11.1.1 Roche Diagnostics Company Detail
11.1.2 Roche Diagnostics Business Overview
11.1.3 Roche Diagnostics Cardiac Marker Testing Introduction
11.1.4 Roche Diagnostics Revenue in Cardiac Marker Testing Business (2019-2024)
11.1.5 Roche Diagnostics Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Detail
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Cardiac Marker Testing Introduction
11.2.4 Abbott Laboratories Revenue in Cardiac Marker Testing Business (2019-2024)
11.2.5 Abbott Laboratories Recent Development
11.3 Siemens
11.3.1 Siemens Company Detail
11.3.2 Siemens Business Overview
11.3.3 Siemens Cardiac Marker Testing Introduction
11.3.4 Siemens Revenue in Cardiac Marker Testing Business (2019-2024)
11.3.5 Siemens Recent Development
11.4 Danaher Corporation
11.4.1 Danaher Corporation Company Detail
11.4.2 Danaher Corporation Business Overview
11.4.3 Danaher Corporation Cardiac Marker Testing Introduction
11.4.4 Danaher Corporation Revenue in Cardiac Marker Testing Business (2019-2024)
11.4.5 Danaher Corporation Recent Development
11.5 Alere Inc
11.5.1 Alere Inc Company Detail
11.5.2 Alere Inc Business Overview
11.5.3 Alere Inc Cardiac Marker Testing Introduction
11.5.4 Alere Inc Revenue in Cardiac Marker Testing Business (2019-2024)
11.5.5 Alere Inc Recent Development
11.6 BioMerieux
11.6.1 BioMerieux Company Detail
11.6.2 BioMerieux Business Overview
11.6.3 BioMerieux Cardiac Marker Testing Introduction
11.6.4 BioMerieux Revenue in Cardiac Marker Testing Business (2019-2024)
11.6.5 BioMerieux Recent Development
11.7 LSI Medience Corporation
11.7.1 LSI Medience Corporation Company Detail
11.7.2 LSI Medience Corporation Business Overview
11.7.3 LSI Medience Corporation Cardiac Marker Testing Introduction
11.7.4 LSI Medience Corporation Revenue in Cardiac Marker Testing Business (2019-2024)
11.7.5 LSI Medience Corporation Recent Development
11.8 Ortho Clinical Diagnostics
11.8.1 Ortho Clinical Diagnostics Company Detail
11.8.2 Ortho Clinical Diagnostics Business Overview
11.8.3 Ortho Clinical Diagnostics Cardiac Marker Testing Introduction
11.8.4 Ortho Clinical Diagnostics Revenue in Cardiac Marker Testing Business (2019-2024)
11.8.5 Ortho Clinical Diagnostics Recent Development
11.9 Randox Laboratories Ltd
11.9.1 Randox Laboratories Ltd Company Detail
11.9.2 Randox Laboratories Ltd Business Overview
11.9.3 Randox Laboratories Ltd Cardiac Marker Testing Introduction
11.9.4 Randox Laboratories Ltd Revenue in Cardiac Marker Testing Business (2019-2024)
11.9.5 Randox Laboratories Ltd Recent Development
11.10 Guangzhou Wondfo Biotech
11.10.1 Guangzhou Wondfo Biotech Company Detail
11.10.2 Guangzhou Wondfo Biotech Business Overview
11.10.3 Guangzhou Wondfo Biotech Cardiac Marker Testing Introduction
11.10.4 Guangzhou Wondfo Biotech Revenue in Cardiac Marker Testing Business (2019-2024)
11.10.5 Guangzhou Wondfo Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock